...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products:(Date:10/8/2008)... BEACH, Fla., Oct. 8 /PRNewswire/ -- The following...-- Congress has made a series of bad,decisions tha... situation,that is decreasing the availability of ...g to healthcare costs. Americans, concerns about a...ase according to recent polls.,Access difficulty i...
(Date:10/8/2008)... Thousands of dental patients wil...h the ALL Care Card. , Cl...card.com [ALL Care Dental Plan], a leading provide... expansion of operations into Illinois, Nevada, Co... can now help dental patients in 42 states save on...
(Date:10/8/2008)... Drug Information Association (DI...mber 5-7; Ottawa, Ontario, Canada) to discuss a nu... pharmaceutical industry, health academia, and the...rsham, PA (PRWEB) October 8, 2008 -- The http://ww...] will host the http://www.diahome.org/diahome/Fla...
(Date:10/8/2008)... Dr. Robert Bernstein, developer ...or hair restoration is featured on the Oprah Winfr... New York, NY (PRWEB) Octo... Bernstein discussing his pioneering follicular un...st diagnostic and treatment techniques for http://...
Breaking Medicine News(10 mins):Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 2Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 3Health News:ALL Care Dental Plan Announces Expansion to New Key States 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Pioneering Hair Transplant Doctor Explains Procedure on Oprah Winfrey Show 2...sity of NSW researchers in Australia are conductin...study could answer some questions about aging. // ...ere are vast differences between them,' study lead...'By studying twins, we will be able to better dete...
...and vegetable juices may have the unique property ...ding to a new study. //US researchers examined mor... the latest issue of the American Journal of Medic...isk of Alzheimer's was reduced by as much as 76 pe...
...s conducted by a researcher from the Institute of ...that human body// is designed to strongly resist a...o prevent weight gain. The findings of the study w...rnational gathering of obesity experts hosted by Q...
...-based Center for Disease Control and Prevention (...elbourne-based pharmaceutical development company/...ndidate vaccine developed by BioDiem and its Dutch...in Atlanta, the US government's leading site for r...
Other Medicine News:Health News:Human Body Designed To Resist Weight Loss 2(Date:10/7/2008)... Showed Larazotide Acetate Prevented Immunologic C...ts with Celiac Disease, Additional Data Indicates ... ORLANDO, Fla., Oct. 7 /- Alba Therap...ical studies this week at the American,College of ...ing. Data from,study CLIN 1001-004, the first Phas...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific ...tCall/ -- Ironwood,Pharmaceuticals, Inc. (formerly...SE: FRX ) today announced the presentation of res... safety and efficacy in 420 patients with,irritabl...is of the data,indicates that once- daily oral dos...
(Date:10/7/2008)...ient, Prospective Randomized Placebo-Controlled Ph...ant Improved Overall Survival., MOUNTAIN VIEW, Ca...peutics has now evaluated the mature Phase II data...idate PROSTVAC(TM) that had been,obtained as part ...nal,Cancer Institute (NCI) in the US., The result...
(Date:10/7/2008)...STGÃ…RD, Denmark, October 7 /PRNewswire-FirstCall/...o-Controlled Phase II Study,Shows Statistically Si...dic has now evaluated the mature phase II data fro...e PROSTVAC(TM) that had been,obtained as part of t...Cancer Institute (NCI) in the US., The results fr...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5NIST announces 56 new awards for innovative technology research and development 604 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 1iCAD to Present at William Blair 26 Company Small Cap Growth Stock Conference 2321 2President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 1President Bush Should Protect Kids Not Big Tobacco By Signing Bill to Increase Cigarette Tax Fund SCHIP 2318 2Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 1Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals 932 2...NESS WIRE)--May 21, 2007 - Gilead Sciences,Inc. (...erm studies,evaluating ambrisentan, an investigati...treatment of patients with pulmonary,arterial hype...ents,who originally participated in the two pivota...study of patients who had,previously discontinued ...
...21, 2007-The U.S. Food and Drug Administration,(FD... Avandia,(rosiglitazone), a drug approved to treat...ical trials have shown that there is a,potentially...and,heart-related deaths in patients taking Avandi...rom long-term clinical trials of,Avandia, includin...
Other Medicine Technology:Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6FDA Issues Safety Alert on Avandia 2FDA Issues Safety Alert on Avandia 3